Literature DB >> 17993263

The molecular functions of Shp2 in the Ras/Mitogen-activated protein kinase (ERK1/2) pathway.

Marie Dance1, Alexandra Montagner, Jean-Pierre Salles, Armelle Yart, Patrick Raynal.   

Abstract

Shp2 is a ubiquitous tyrosine phosphatase containing Src Homology 2 domains which plays major biological functions in response to various growth factors, hormones or cytokines. This is essentially due to its particularity of promoting the activation of the Ras/Mitogen-activated protein kinase pathway. Recent progresses have been made in the understanding of the molecular mechanisms involved in this regulation. We review here, and discuss the physiological relevance, of the following molecular functions of Shp2 that have been proposed to couple the phosphatase to Ras activation: promoter of Grb2/Sos recruitment through direct binding to Grb2, binding partner and regulator of SHPS-1, negative regulator of Sprouty, negative regulator of RasGAP recruitment, and activator of Src through dephosphorylation of Src-regulatory proteins.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17993263     DOI: 10.1016/j.cellsig.2007.10.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  147 in total

1.  Noonan syndrome: clinical aspects and molecular pathogenesis.

Authors:  M Tartaglia; G Zampino; B D Gelb
Journal:  Mol Syndromol       Date:  2010-01-15

2.  Gab1 mediates hepatocyte growth factor-stimulated mitogenicity and morphogenesis in multipotent myeloid cells.

Authors:  Angelina Felici; Alessio Giubellino; Donald P Bottaro
Journal:  J Cell Biochem       Date:  2010-10-01       Impact factor: 4.429

Review 3.  Molecular Pathways: Targeting Protein Tyrosine Phosphatases in Cancer.

Authors:  Lakshmi Reddy Bollu; Abhijit Mazumdar; Michelle I Savage; Powel H Brown
Journal:  Clin Cancer Res       Date:  2017-01-13       Impact factor: 12.531

Review 4.  RAS-targeted therapies: is the undruggable drugged?

Authors:  Amanda R Moore; Scott C Rosenberg; Frank McCormick; Shiva Malek
Journal:  Nat Rev Drug Discov       Date:  2020-06-11       Impact factor: 84.694

5.  Targeting PDGFRα-activated glioblastoma through specific inhibition of SHP-2-mediated signaling.

Authors:  Youzhou Sang; Yanli Hou; Rongrong Cheng; Liang Zheng; Angel A Alvarez; Bo Hu; Shi-Yuan Cheng; Weiwei Zhang; Yanxin Li; Haizhong Feng
Journal:  Neuro Oncol       Date:  2019-11-04       Impact factor: 12.300

6.  The protein tyrosine phosphatase SHP-2 is required for EGFRvIII oncogenic transformation in human glioblastoma cells.

Authors:  Yi Zhan; George J Counelis; Donald M O'Rourke
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

7.  Identification of cryptotanshinone as an inhibitor of oncogenic protein tyrosine phosphatase SHP2 (PTPN11).

Authors:  Wei Liu; Bing Yu; Gang Xu; Wei-Ren Xu; Mignon L Loh; Li-Da Tang; Cheng-Kui Qu
Journal:  J Med Chem       Date:  2013-09-04       Impact factor: 7.446

Review 8.  Receptor tyrosine kinase (RTK) signalling in the control of neural stem and progenitor cell (NSPC) development.

Authors:  Alexander Annenkov
Journal:  Mol Neurobiol       Date:  2013-08-28       Impact factor: 5.590

9.  The 11-Kilodalton Nonstructural Protein of Human Parvovirus B19 Facilitates Viral DNA Replication by Interacting with Grb2 through Its Proline-Rich Motifs.

Authors:  Peng Xu; Aaron Yun Chen; Safder S Ganaie; Fang Cheng; Weiran Shen; Xiaomei Wang; Steve Kleiboeker; Yi Li; Jianming Qiu
Journal:  J Virol       Date:  2018-12-10       Impact factor: 5.103

10.  Epithelial tyrosine phosphatase SHP-2 protects against intestinal inflammation in mice.

Authors:  Geneviève Coulombe; Caroline Leblanc; Sébastien Cagnol; Faiza Maloum; Etienne Lemieux; Nathalie Perreault; Gen-Sheng Feng; François Boudreau; Nathalie Rivard
Journal:  Mol Cell Biol       Date:  2013-03-25       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.